Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs

Схожие документы

• The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
  по: Abrams, Stephen L., et al.
  Опубликовано: (2010)
• Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance
  по: McCubrey, James A., et al.
  Опубликовано: (2007)
• ROLES OF THE RAF/MEK/ERK PATHWAY IN CELL GROWTH, MALIGNANT TRANSFORMATION AND DRUG RESISTANCE
  по: McCubrey, James A., et al.
  Опубликовано: (2006)
• Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines
  по: Chappell, William H., et al.
  Опубликовано: (2020)
• Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy
  по: Abrams, Stephen L., et al.
  Опубликовано: (2010)